m6A reader IGF2BP2 Mediates Airway Remodeling by Stabilizing Dixdc1 in Asthma Pathogenesis

Pulmonary Pharmacology and Therapeutics · Published 2026-07-01 · DOI 10.1016/j.pupt.2026.102438

Authors (8)

Xiao-Mang Li, Bi-Wen Mo, Yan Gao, Yun-Xiang Chen, Bo Xiao, Yue Gu, Miao-Miao Liang, Hui-Min Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, X., Mo, B., Gao, Y., et al. (2026). m6A reader IGF2BP2 Mediates Airway Remodeling by Stabilizing Dixdc1 in Asthma Pathogenesis. Pulmonary Pharmacology and Therapeutics. https://doi.org/10.1016/j.pupt.2026.102438

Related articles

• Emerging Therapeutic Strategies in Asthma: Advances in Treatment, Drug Delivery, Drug Adherence, and Disease Management · Current Allergy and Asthma Reports · 2026 · Cites or is cited by this article
• Multi-Dimensional Perspective of the Gene and Environmental Interaction in Asthma · Clinical Reviews in Allergy and Immunology · 2026 · Cites or is cited by this article
• Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients · Pulmonary Pharmacology and Therapeutics · 2026 · Same journal
• Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia · Pulmonary Pharmacology and Therapeutics · 2024 · Same journal
• Prevalence and clinical significance of pre- and post-bronchodilator airflow obstruction in COPD patients · Pulmonary Pharmacology and Therapeutics · 2024 · Same journal
• Drug-drug interactions in vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor-ivacaftor · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal
• Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal
• Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal
• Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment · Pulmonary Pharmacology and Therapeutics · 2026 · Same journal
• Clinical remission at two years post-diagnosis of asthma and its association with clinical outcomes: A retrospective cohort study in asthma patients with maintenance inhaler therapy · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal